. Author manuscript; available in PMC: 2012 Oct 1.

Published in final edited form as: Behav Brain Res. 2011 May 6;223(2):322–328. doi: 10.1016/j.bbr.2011.04.048

Table 1.

Mean DOPAC and Dopamine Content (+/−SEM) in the NAc and mPFC following Intra-VTAPTX Treatment

Brain Region	Intra-VTA Treatment	Sample Size	DOPAC (ng/mg protein)	Dopamine (ng/mg protein)	DOPAC/DA Ratio
N. Accumbens	Control	6	31.58 (2.60)	169.30 (14.81)	0.132 (0.004)
	PTX (0 3 μg)	6	25.20 (7.24)	107.45 (34.86)	0.168 (0.02)
			T(10)=0.83, P<0.43	T(10)=1.63, P<0.134	T(0)=1.51, P<0.161
mPFC	Control	6	58.43 (24.60)	143.06 (52.32)	0.152 (0.019)
	PTX (0 3 μg)	6	85.67 (48.70)	242.53 (105.85)	0.139 (0.028)
			T(10)=0.50, P<0.628	T(10)=0.84, P<0.419	T(10)=0.37, P<0.719